KFF Health News’ ‘What the Health?’: Anti-abortion hard-liners speak up

FHS
May 23, 2024
8:28 pm

With abortion shaping up as a key issue for the November elections, the movement that united to overturn Roe v. Wade is divided over going further, faster — including by punishing those who have abortions and banning contraception or IVF.

Coeptis licenses Deverra Therapeutics’ clinical stage assets

DVX201 is being assessed in a Phase I clinical study for treating haematologic malignancies and viral infections. Credit: Kateryna Kon/Shutterstock.com. Coeptis Therapeutics has exclusively licensed

August 18, 2023

Exercise promotes nerve growth at the cellular level

There’s no doubt that exercise does a body good. Regular activity not only strengthens muscles but can bolster our bones, blood vessels, and immune system.

November 12, 2024

‘Underwhelming’: NIH trials fail to test meaningful long Covid treatments — after 2.5 years and $1 billion

More than 2.5 years after the National Institutes of Health received a $1 billion mandate from Congress to study and treat long Covid, the agency

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.